$Novo-Nordisk A/S(NVO)$  COPENHAGEN, Jan 5 (Reuters) - Denmark's Novo Nordisk NOVOb.CO will offer its 1.5 and 4 milligram Wegovy weightloss pills at $149 per month to self-paying patients in the United States from January 5, it said on Monday.


It will offer the highest doses of the drug pill, of 9 and 25 milligram, at $299 per month, it said on its website.


Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet